These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31046927)

  • 1. Pharmacologic Treatment of Eating Disorders.
    Crow SJ
    Psychiatr Clin North Am; 2019 Jun; 42(2):253-262. PubMed ID: 31046927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychopharmacologic treatment of eating disorders: emerging findings.
    McElroy SL; Guerdjikova AI; Mori N; Keck PE
    Curr Psychiatry Rep; 2015 May; 17(5):35. PubMed ID: 25796197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacological advances in eating disorders.
    Himmerich H; Treasure J
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):95-108. PubMed ID: 28933969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of eating disorders with concurrent ADHD symptoms: knowledge, knowledge gaps and clinical implications].
    Svedlund NE; Norring C; Ginsberg Y; von Hausswolff-Juhlin Y
    Lakartidningen; 2019 Sep; 116():. PubMed ID: 31529419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of pharmacotherapy options for bulimia nervosa and binge eating disorder.
    Bello NT; Yeomans BL
    Expert Opin Drug Saf; 2018 Jan; 17(1):17-23. PubMed ID: 29053927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacologic Management of Eating Disorders.
    Muratore AF; Attia E
    Curr Psychiatry Rep; 2022 Jul; 24(7):345-351. PubMed ID: 35576089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential role of stimulants in treating eating disorders.
    Keshen A; Bartel S; Frank GKW; Svedlund NE; Nunes A; Dixon L; Ali SI; Kaplan AS; Hay P; Touyz S; Romo-Nava F; McElroy SL
    Int J Eat Disord; 2022 Mar; 55(3):318-331. PubMed ID: 34846763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders.
    Aigner M; Treasure J; Kaye W; Kasper S;
    World J Biol Psychiatry; 2011 Sep; 12(6):400-43. PubMed ID: 21961502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis.
    Brownley KA; Berkman ND; Peat CM; Lohr KN; Cullen KE; Bann CM; Bulik CM
    Ann Intern Med; 2016 Sep; 165(6):409-20. PubMed ID: 27367316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In brief: lisdexamfetamine (Vyvanse) for binge eating disorder.
    Med Lett Drugs Ther; 2015 Mar; 57(1464):42. PubMed ID: 25758546
    [No Abstract]   [Full Text] [Related]  

  • 11. A feasibility study evaluating lisdexamfetamine dimesylate for the treatment of adults with bulimia nervosa.
    Keshen AR; Dixon L; Ali SI; Helson T; Nunes A; Milliken H; Gamberg S; Sadek J; Kaplan A; McElroy SL
    Int J Eat Disord; 2021 May; 54(5):872-878. PubMed ID: 33534199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in therapies for eating disorders.
    Davis LE; Attia E
    F1000Res; 2019; 8():. PubMed ID: 31598212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic Medication for Children and Adolescents with Eating Disorders.
    Couturier J; Isserlin L; Spettigue W; Norris M
    Child Adolesc Psychiatr Clin N Am; 2019 Oct; 28(4):583-592. PubMed ID: 31443877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in Developing Pharmacologic Agents to Treat Bulimia Nervosa.
    McElroy SL; Guerdjikova AI; Mori N; Romo-Nava F
    CNS Drugs; 2019 Jan; 33(1):31-46. PubMed ID: 30523523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lisdexamfetamine in Pediatric Binge Eating Disorder: A Retrospective Chart Review.
    Guerdjikova AI; Blom TJ; Mori N; Matthews A; Cummings T; Casuto LL; McElroy SL
    Clin Neuropharmacol; 2019; 42(6):214-216. PubMed ID: 31725476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lisdexamfetamine for binge eating disorder in adults: a systematic review of the efficacy and safety profile for this newly approved indication - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2015 Apr; 69(4):410-21. PubMed ID: 25752762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating Disorder: A Randomized Clinical Trial.
    Hudson JI; McElroy SL; Ferreira-Cornwell MC; Radewonuk J; Gasior M
    JAMA Psychiatry; 2017 Sep; 74(9):903-910. PubMed ID: 28700805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial.
    Guerdjikova AI; Mori N; Blom TJ; Keck PE; Williams SL; Welge JA; McElroy SL
    Hum Psychopharmacol; 2016 Sep; 31(5):382-91. PubMed ID: 27650406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binge-Eating Disorder.
    Hilbert A
    Psychiatr Clin North Am; 2019 Mar; 42(1):33-43. PubMed ID: 30704638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of eating disorders.
    Jackson CW; Cates M; Lorenz R
    Nutr Clin Pract; 2010 Apr; 25(2):143-59. PubMed ID: 20413695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.